Skip to main content

Table 1 Main patient characteristics

From: High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease

Patient no. Gender Age (years) SAPS II (at ICU admission) SOFA (day of study) Reason for admission to ICU FEV1/FVC
(% predicted)
FEV1
(% predicted)
GOLD stage Days of MV Reintubation ICU length of stay (days) Hospital outcome
1 M 70 27 3 COPD exacerbation 63 30 3 4 No 7 Survivor
2 M 84 42 4 Postoperative respiratory failure (abdominal sepsis) 68 33 3 14 No 20 Survivor
3 M 70 40 7 Hemorrhagic shock (trauma) 48 53 2 12 No 14 Survivor
4 M 80 36 6 COPD exacerbation 42 55 2 11 Yes 29 Nonsurvivor
5 M 72 58 7 COPD exacerbation 62 55 2 8 No 10 Survivor
6 F 76 58 10 Postoperative respiratory failure (abdominal sepsis) 50 24 4 12 No 13 Survivor
7 M 58 50 10 COPD exacerbation 52 32 3 5 No 11 Survivor
8 M 78 43 5 Postoperative respiratory failure (hip Fracture) 59 27 4 3 Yes 25 Nonsurvivor
9 F 71 54 8 COPD exacerbation 47 25 4 4 No 6 Survivor
10 M 76 31 5 Postoperative respiratory failure (abdominal sepsis) 56 49 3 4 No 5 Survivor
11 M 64 29 3 COPD exacerbation 57 46 3 10 Yes 20 Survivor
12 M 50 10 2 COPD exacerbation 64 64 2 6 No 14 Survivor
13 M 78 35 4 COPD exacerbation 53 59 2 8 Yes 24 Nonsurvivor
14 M 74 42 5 Postoperative respiratory failure (abdominal sepsis) 44 64 2 4 Yes 23 Nonsurvivor
Mean ± SD   71.5
9
39.6
13.2
5.6
2.5
     7.5
3.7
Reintubation
5/14 (35.7%)
  Survival
10/14 (71.4%)
  1. COPD chronic obstructive pulmonary disease, F female, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, GOLD Global Initiative for Chronic Lung Disease, ICU intensive care unit, M male, MV mechanical ventilation, SAPS Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment